Reported Tuberculosis in the United States, 2021

Return to Main Menu

Table 45. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility Testing (DST) Results by Resistance to Isoniazid or Multidrug Resistance (MDR): Reporting Areas, 2021

Culture-positive tuberculosis cases and percentages with drug-susceptibility testing reports by type of drug resistance and reporting area.
Reporting area Total cases1 Initial DST performed2 Isoniazid-resistant3 MDR4
No. (%) No. (%) No. (%)
United States5 6,252 6,005 (96.0) 536 (8.9) 77 (1.3)
Alabama 82 77 (93.9) 3 (3.9) 0 (0.0)
Alaska 44 44 (100.0) 4 (9.1) 0 (0.0)
Arizona 105 105 (100.0) 8 (7.6) 0 (0.0)
Arkansas 51 50 (98.0) 0 (0.0) 0 (0.0)
California 1,419 1,366 (96.3) 130 (9.5) 12 (0.9)
Colorado 45 45 (100.0) 3 (6.7) 0 (0.0)
Connecticut 44 44 (100.0) 8 (18.2) 2 (4.5)
Delaware 32 29 (90.6) 0 (0.0) 0 (0.0)
District of Columbia 16 16 (100.0) 1 (6.3) 1 (6.3)
Florida 385 365 (94.8) 21 (5.8) 1 (0.3)
Georgia 178 154 (86.5) 17 (11.0) 5 (3.2)
Hawaii 77 76 (98.7) 15 (19.7) 0 (0.0)
Idaho 4 4 (100.0) 0 (0.0) 0 (0.0)
Illinois 196 184 (93.9) 11 (6.0) 3 (1.6)
Indiana 95 95 (100.0) 6 (6.3) 0 (0.0)
Iowa 36 35 (97.2) 3 (8.6) 1 (2.9)
Kansas 38 36 (94.7) 4 (11.1) 3 (8.3)
Kentucky 41 41 (100.0) 1 (2.4) 0 (0.0)
Louisiana 74 73 (98.6) 2 (2.7) 0 (0.0)
Maine 11 11 (100.0) 1 (9.1) 0 (0.0)
Maryland 138 129 (93.5) 4 (3.1) 1 (0.8)
Massachusetts 127 123 (96.9) 14 (11.4) 0 (0.0)
Michigan 83 81 (97.6) 10 (12.3) 2 (2.5)
Minnesota 94 94 (100.0) 9 (9.6) 4 (4.3)
Mississippi 38 35 (92.1) 1 (2.9) 0 (0.0)
Missouri 59 56 (94.9) 3 (5.4) 0 (0.0)
Montana 2 2 (100.0) 0 (0.0) 0 (0.0)
Nebraska 19 16 (84.2) 2 (12.5) 0 (0.0)
Nevada 55 55 (100.0) 8 (14.5) 1 (1.8)
New Hampshire 12 12 (100.0) 0 (0.0) 0 (0.0)
New Jersey 231 222 (96.1) 35 (15.8) 10 (4.5)
New Mexico 16 16 (100.0) 0 (0.0) 0 (0.0)
New York State6 128 127 (99.2) 12 (9.4) 2 (1.6)
New York City 442 429 (97.1) 38 (8.9) 6 (1.4)
North Carolina 147 146 (99.3) 8 (5.5) 0 (0.0)
North Dakota 14 0 (0.0) 0 0
Ohio 100 94 (94.0) 7 (7.4) 0 (0.0)
Oklahoma 36 35 (97.2) 2 (5.7) 0 (0.0)
Oregon 65 65 (100.0) 0 (0.0) 0 (0.0)
Pennsylvania 140 137 (97.9) 16 (11.7) 5 (3.6)
Rhode Island 12 12 (100.0) 0 (0.0) 0 (0.0)
South Carolina 73 72 (98.6) 6 (8.3) 2 (2.8)
South Dakota 9 9 (100.0) 2 (22.2) 0 (0.0)
Tennessee 56 54 (96.4) 4 (7.4) 0 (0.0)
Texas 811 769 (94.8) 72 (9.4) 7 (0.9)
Utah 11 11 (100.0) 1 (9.1) 0 (0.0)
Vermont 3 3 (100.0) 1 (33.3) 0 (0.0)
Virginia 136 136 (100.0) 16 (11.8) 0 (0.0)
Washington 161 158 (98.1) 22 (13.9) 6 (3.8)
West Virginia 3 3 (100.0) 0 (0.0) 0 (0.0)
Wisconsin 56 54 (96.4) 5 (9.3) 3 (5.6)
Wyoming 2 0 (0.0) 0 0
American Samoa 4 4 (100.0) 0 (0.0) 0 (0.0)
Federated States of Micronesia 29 21 (72.4) 0 (0.0) 0 (0.0)
Guam 39 38 (97.4) 4 (10.5) 1 (2.6)
Republic of the Marshall Islands 26 16 (61.5) 0 (0.0) 0 (0.0)
Northern Mariana Islands 12 10 (83.3) 0 (0.0) 0 (0.0)
Puerto Rico 16 15 (93.8) 0 (0.0) 0 (0.0)
Republic of Palau 6 0 (0.0) 0 0
U.S. Virgin Islands 0 0 0 0

1Culture-positive cases.
2Persons with isolates tested with at least isoniazid and rifampin.
3Resistant to at least isoniazid.
4Resistant to at least isoniazid and rifampin.
5American Samoa, Federated States of Micronesia, Guam, Republic of the Marshall Islands, Northern Mariana Islands, Puerto Rico, Republic of Palau, and U.S. Virgin Islands are not included in the U.S. totals and percentages.
6Excludes New York City.

Note:
Ellipses (…) indicate that the percentage cannot be calculated, and the denominator is 0.